Next-generation TCR sequencing – a tool to understand T-cell infiltration in human cancers

Journal of Pathology

Volumn 240, Issue 4, 2016, Pages 384-386

  Poschke, Isabel ^a   Flossdorf, Michael ^b   Offringa, Rienk ^a,c  

^a GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^b TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^c UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

Author keywords

next generation sequencing; oesophageal cancer; T cell receptor repertoire; tumour infiltrating lymphocytes

Indexed keywords

T LYMPHOCYTE RECEPTOR;

CANCER IMMUNOTHERAPY; CANCER PATIENT; HUMAN; LYMPHOCYTIC INFILTRATION; MALIGNANT NEOPLASTIC DISEASE; NEXT GENERATION SEQUENCING; NOTE; PRIORITY JOURNAL; T LYMPHOCYTE; TREATMENT RESPONSE; HIGH THROUGHPUT SEQUENCING; TUMOR ASSOCIATED LEUKOCYTE; UNITED KINGDOM;

HIGH-THROUGHPUT NUCLEOTIDE SEQUENCING; HUMANS; LYMPHOCYTES, TUMOR-INFILTRATING; T-LYMPHOCYTES; UNITED KINGDOM;

EID: 84995550241     PISSN: 00223417     EISSN: 10969896     Source Type: Journal    
DOI: 10.1002/path.4800     Document Type: Note

References (16)

1. Rosenberg SA, Restifo NP. Adoptive cell transfer as personalized immunotherapy for human cancer. Science 2015; 348: 62–68.
2. Topalian SL, Drake CG, Pardoll DM. Immune checkpoint blockade: a common denominator approach to cancer therapy. Cancer Cell 2015; 27: 450–461.
3. Chen Z, Zhang C, Pan Y, et al. T cell receptor beta-chain repertoire analysis reveals intratumour heterogeneity of tumour-infiltrating lymphocytes in oesophageal squamous cell carcinoma. J Pathol 2016; 239: 450–458.
4. Sherwood AM, Emerson RO, Scherer D, et al. Tumor-infiltrating lymphocytes in colorectal tumors display a diversity of T cell receptor sequences that differ from the T cells in adjacent mucosal tissue. Cancer Immunol Immunother 2013; 62: 1453–1461.
5. + tumor-reactive repertoire infiltrating human tumors. J Clin Invest 2014; 124: 2246–2259.
6. Pasetto A, Gross A, Robbins PF, et al. Tumor- and neoantigen-reactive T-cell receptors can be identified based on their frequency in fresh tumor. Cancer Immunol Res 2016; 4: 734–743.
7. Gerlinger M, Quezada SA, Peggs KS, et al. Ultra-deep T cell receptor sequencing reveals the complexity and intratumour heterogeneity of T cell clones in renal cell carcinomas. J Pathol 2013; 231: 424–432.
8. Emerson RO, Sherwood AM, Rieder MJ, et al. High-throughput sequencing of T-cell receptors reveals a homogeneous repertoire of tumour-infiltrating lymphocytes in ovarian cancer. J Pathol 2013; 231: 433–440.
9. Cha E, Klinger M, Hou Y, et al. Improved survival with T cell clonotype stability after anti-CTLA-4 treatment in cancer patients. Sci Transl Med 2014; 6: 238ra270.
10. Postow MA, Manuel M, Wong P, et al. Peripheral T cell receptor diversity is associated with clinical outcomes following ipilimumab treatment in metastatic melanoma. J Immunother Cancer 2015; 3: 23.
11. Tumeh PC, Harview CL, Yearley JH, et al. PD-1 blockade induces responses by inhibiting adaptive immune resistance. Nature 2014; 515: 568–571.
12. Best K, Oakes T, Heather JM, et al. Computational analysis of stochastic heterogeneity in PCR amplification efficiency revealed by single molecule barcoding. Sci Rep 2015; 5: 14629.
13. Shugay M, Britanova OV, Merzlyak EM, et al. Towards error-free profiling of immune repertoires. Nature Methods 2014; 11: 653–655.
14. Howie B, Sherwood AM, Berkebile AD, et al. High-throughput pairing of T cell receptor alpha and beta sequences. Sci Transl Med 2015; 7: 301ra131.
15. Linnemann C, Heemskerk B, Kvistborg P, et al. High-throughput identification of antigen-specific TCRs by TCR gene capture. Nature Med 2013; 19: 1534–1541.
16. Turchaninova MA, Britanova OV, Bolotin DA, et al. Pairing of T-cell receptor chains via emulsion PCR. Eur J Immunol 2013; 43: 2507–2515.